HDAC activity inhibition abolishes pluripotency, proliferation and survival pathways leading Ewing sarcoma cells to a differentiated state

dc.contributor.author	Souza, Bárbara Kunzler	pt_BR
dc.contributor.author	Lopez, Patrícia Luciana da Costa	pt_BR
dc.contributor.author	Menegotto, Pamela Rossi	pt_BR
dc.contributor.author	Vieira, Igor Araújo	pt_BR
dc.contributor.author	Kersting, Nathalia	pt_BR
dc.contributor.author	Abujamra, Ana Lúcia	pt_BR
dc.contributor.author	Gregianin, Lauro José	pt_BR
dc.contributor.author	Brunetto, Algemir Lunardi	pt_BR
dc.contributor.author	Farias, Caroline Brunetto de	pt_BR
dc.contributor.author	Roesler, Rafael	pt_BR
dc.date.accessioned	2017-08-31T02:31:48Z	pt_BR
dc.date.issued	2016	pt_BR
dc.identifier.uri	http://hdl.handle.net/10183/165978	pt_BR
dc.format.mimetype	application/pdf
dc.language.iso	por	pt_BR
dc.relation.ispartof	Clinical and biomedical research. Porto Alegre	pt_BR
dc.rights	Open Access	en
dc.subject	Medicina	pt_BR
dc.title	HDAC activity inhibition abolishes pluripotency, proliferation and survival pathways leading Ewing sarcoma cells to a differentiated state	pt_BR
dc.type	Resumo publicado em evento	pt_BR
dc.contributor.event	Hospital de Clínicas de Porto Alegre. Semana Científica. (36. : 2016 : Porto Alegre, RS)	pt_BR
dc.identifier.nrb	001006099	pt_BR
dc.type.origin	Nacional	pt_BR

Este item está licenciado na Creative Commons License